Back to Journals » ClinicoEconomics and Outcomes Research » Volume 13

Budgetary Impact of Bendamustine Ready-to-Dilute Products in Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma to a United States Infusion Facility

Total article views   HTML views PDF downloads Totals
6,533 Dovepress* 5,790+ 760 6,550
PubMed Central* 743 154 897
Totals 6,533 914 7,447
*Since 22 March 2021
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed and Google Scholar